TrialJournal for immunotherapy of cancer2021

Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients.

Alexandre Gérard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.